101 related articles for article (PubMed ID: 5781327)
1. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
Gambini G; Grisler R
Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
[No Abstract] [Full Text] [Related]
2. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
Bellomo A; Strobbia R; Manzoni A
Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
[No Abstract] [Full Text] [Related]
3. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
Borellini D; Milvio C
Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
[No Abstract] [Full Text] [Related]
4. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
Bianchi PG; Saccabusi E
Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
[No Abstract] [Full Text] [Related]
5. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
[No Abstract] [Full Text] [Related]
6. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
Uzeta Mejia S
Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
[No Abstract] [Full Text] [Related]
7. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
Linati E
Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
[No Abstract] [Full Text] [Related]
8. [Use of Xylamide (MILID) as an antisecretory-antigastrinic agent in acute pancreatitis].
Margnelli M; Zacco R; Velati GF
Minerva Gastroenterol; 1969; 15(4):229-34. PubMed ID: 5379889
[No Abstract] [Full Text] [Related]
9. [Pharmacological and clinical studies of a non-anticholinergic antisecretory product: Milid (xylamide, CR 242)].
Mainoli S; Milvio C; Borellini D
Minerva Med; 1967 Oct; 58(86):3708-12. PubMed ID: 6061066
[No Abstract] [Full Text] [Related]
10. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
Sampietro R
Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
[No Abstract] [Full Text] [Related]
11. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
[No Abstract] [Full Text] [Related]
12. [Results obtained with Dogmagel in the treatment of gastroduodenal ulcer and gastroduodenitis].
Sánchez García-Moreno I
Rev Esp Enferm Apar Dig; 1974 Dec; 44(7):743-6. PubMed ID: 4445556
[No Abstract] [Full Text] [Related]
13. [Therapeutic value of the combination of a corticosteroid (prednisone) with a gastroprotective substance (xylamide)].
Abbona C; Marugo M; Berretti A
Minerva Med; 1972 Sep; 63(60):3258-65. PubMed ID: 4559865
[No Abstract] [Full Text] [Related]
14. [Our experience in the therapy of gastrointestinal diseases (peptic ulcer and gastroduodenitis) with methachlopramide].
Arias Vallejo E; Galán Navarro JL
Rev Clin Esp; 1967 Feb; 104(3):248-55. PubMed ID: 5597813
[No Abstract] [Full Text] [Related]
15. [Personal experience in the treatment of stomach diseases (peptic ulcer and gastroduodenitis) with a synthesis of metachlopramide and beta-glycirrhetic acid].
Lopez-Calderon Barreda ; Barado Sanchez F; Garcia Perez M
Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):783-94. PubMed ID: 5503933
[No Abstract] [Full Text] [Related]
16. [Clinical considerations on the therapeutic effect of a new non-anticholinergic antisecretory preparation: Milid (xylamide, CR 242)].
Castelli CA; Locatelli L; Salvioni GF
Minerva Med; 1967 Oct; 58(86):3704-8. PubMed ID: 6061065
[No Abstract] [Full Text] [Related]
17. [Effects of propaxoline therapy on gastroduodenal inflammation. Radiological, endoscopic, bioptic and functional studies of the stomach and duodenum].
Gasbarrini G; Faggioli F; Melchionda N; Miglio F; Zanetti A
Minerva Med; 1970 Sep; 61(71):3643-66. PubMed ID: 5454749
[No Abstract] [Full Text] [Related]
18. [Evaluation of the inhibiting activity of a new parasympatholytic, Ketoscilium, on gastric secretion in humans].
Lodola E
Minerva Gastroenterol; 1970; 16(2):99-103. PubMed ID: 5477403
[No Abstract] [Full Text] [Related]
19. [Effect, on gastric absorption, of a new molecule with mucopoietic activity, 2-)p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine, used in therapy of gastroduodenal diseases].
Barlattani M
Clin Ter; 1971 Dec; 59(5):417-30. PubMed ID: 5159600
[No Abstract] [Full Text] [Related]
20. [New therapeutic aspects in substitutive treatment with homologous and heterologous enzymes of gastro-entero-biliary hyposthenic diseases].
Palmari V; Pietranera P
Clin Ter; 1970 May; 53(4):299-313. PubMed ID: 4918645
[No Abstract] [Full Text] [Related]
[Next] [New Search]
